Clinically administered ketamine shows positive outcomes for Angela’s treatment-resistant depression

[ad_1]

Once a week, Angela Neale pops on some headphones and plays her favourite tracks by singer-songwriter Enya. 

But before that she takes a ketamine nasal spray — a drug she says helps manage her treatment-resistant depression.

“You feel quite funny, sort of out of your body for a little while,” Ms Neale said.

She said the benefits really started when the effects of the drug wore off.

“You start to think in different ways. The sad thoughts that go round and round tend to stop. You’re more flexible in your mind,” Ms Neale said.

A woman sits inside a clinic with headphones on

Ms Neale is part of a small group to receive the treatment, although she isn’t undergoing the treatment in this photo.(ABC Gold Coast: Nicholas McElroy)

She is part of a small group who are now regularly treated with ketamine in a clinical setting at the Gold Coast University Hospital. 

After years of studies with some promising outcomes, it is one of a few publicly funded clinics nationwide offering the drug.

Why does this matter?

One in seven Australians will experience depression in their lifetime, according to the Black Dog Institute.

It is also a leading cause of ill health and disability globally according to the World Health Organization.

Sources

1/ https://Google.com/

2/ https://www.abc.net.au/news/2024-05-17/ketamine-for-treatment-resistant-depression-gold-coast-clinic/103762614

The mention sources can contact us to remove/changing this article

[ad_2]

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts